Ranluspec (ranluspec) 10 mg/ml Solution for Injection

What Is Ranluspec and What Is It Used For?

Ranluspec is a prescription-only injectable medicine containing ranluspec as its active substance, supplied as a 10 mg/ml sterile solution. It is used for specific medical indications described in its approved prescribing information and must be administered by, or under the supervision of, a qualified healthcare professional.

Ranluspec is a parenteral medicine, meaning it is administered directly into the body by injection rather than taken by mouth. The injectable route is chosen when an oral formulation is unsuitable — for example, because the active substance would be destroyed by stomach acid, poorly absorbed from the intestine, or would not reach its target tissues in adequate concentrations. Injection also allows for more predictable drug levels in the bloodstream, which can be important for medicines with a narrow therapeutic window.

Each millilitre of Ranluspec solution contains 10 milligrams of the active ingredient ranluspec, together with inactive excipients that maintain the sterility, stability, and pH of the formulation. Because the product is marketed as a prescription-only medicine (often abbreviated "Rx" or "POM" — "prescription-only medicine"), it cannot be bought over the counter and must be supplied against a prescription issued by a doctor, nurse prescriber, dentist, or other authorised healthcare professional.

The precise conditions for which Ranluspec is approved and prescribed are described in its official product literature, including the Summary of Product Characteristics (SmPC) issued by regulatory authorities such as the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA), or national agencies. Your prescriber will explain why this medicine has been recommended for you, what outcome is expected, and how success of the treatment will be monitored. You should always read the patient information leaflet that is supplied inside the carton.

How Ranluspec Is Supplied

Ranluspec is available as a ready-to-use sterile solution at a concentration of 10 mg/ml. Injectable solutions of this type are usually provided in single-use ampoules, vials, or pre-filled syringes, each designed for one patient and one administration. The packaging, volume per container, and pack sizes authorised in your country are listed on the outer carton and in the product leaflet. Do not use the medicine if the carton or container is damaged, the expiry date has passed, or the solution looks discoloured, cloudy, or contains visible particles.

Who Prescribes and Administers Ranluspec

As a prescription-only injectable medicine, Ranluspec is typically administered in a clinical setting — such as a hospital ward, day-care unit, outpatient clinic, or general practice surgery — by a doctor, nurse, or other qualified healthcare professional. In some cases, and only if the product information supports it, patients or their carers may be trained to give the injection themselves at home. Training includes choosing the correct injection site, using aseptic technique, disposing of needles safely, and recognising when to seek medical help.

What Should You Know Before Taking Ranluspec?

Before receiving Ranluspec, your doctor will review your full medical history, any allergies, your current medicines, pregnancy or breastfeeding status, and your organ function. Ranluspec should not be used if you are allergic to ranluspec or to any excipient in the formulation. Special precautions apply during pregnancy, breastfeeding, and in patients with pre-existing conditions.

Before starting treatment with any injectable medicine, a careful clinical assessment reduces the chance of avoidable harm. Your prescriber will ask about previous reactions to medicines or vaccines, current and past illnesses, family medical history, and any non-prescription products you use — including vitamins, mineral supplements, and herbal remedies. Tell your healthcare team if you drink alcohol regularly, smoke, or use recreational substances, because these factors can influence both how the medicine works and how side effects are managed.

Contraindications

You must not receive Ranluspec if any of the following apply:

• You are allergic (hypersensitive) to ranluspec or to any of the other ingredients listed in the patient information leaflet
• You have had a previous severe reaction — such as anaphylaxis, bronchospasm, or widespread rash — to this medicine or to a closely related product
• The prescribing information identifies a specific condition for which the medicine must not be used, and you have that condition

If you are unsure whether any of these situations apply to you, discuss your concerns with your doctor or pharmacist before the first injection. Carrying an up-to-date list of your allergies and medicines makes these conversations easier and safer.

Warnings and Precautions

Talk to your doctor, pharmacist, or nurse before receiving Ranluspec if any of the following apply:

• Kidney or liver problems: Reduced organ function can alter how the medicine is processed and may require dose adjustment or closer monitoring
• Heart conditions: Pre-existing heart disease, heart rhythm disorders, or uncontrolled hypertension may influence the choice of dose and the need for observation
• Bleeding or clotting disorders: Conditions that increase bleeding risk, or treatment with anticoagulants, may affect how and where the injection is given
• Immune-system problems: Immunosuppression, active infection, or a weakened immune system require special evaluation before starting injectable therapy
• Previous drug reactions: Any history of severe skin reaction, angioedema, or anaphylaxis to medicines should be discussed
• Recent or planned surgery: Tell your surgical team about all medicines you take, including Ranluspec
• Recent vaccination: The timing of routine or travel vaccines may need to be coordinated with your prescriber

Tests and Monitoring

Your doctor may request blood tests, organ-function tests, or other investigations before starting Ranluspec and during treatment. Depending on your individual situation, monitoring may include:

• Baseline blood tests to check kidney and liver function
• Full blood count to evaluate red blood cells, white blood cells, and platelets
• Electrolytes, glucose, and other biochemistry markers when relevant
• Electrocardiogram (ECG) if there is any concern about heart rhythm
• Pregnancy testing in women of childbearing potential when the prescribing information requires it

Attending all scheduled follow-up appointments allows early detection of side effects and confirms that the medicine is working as expected. If new symptoms develop between visits, do not wait for your next appointment — contact your healthcare team for advice.

Pregnancy and Breastfeeding

If you are pregnant, think you may be pregnant, are planning a pregnancy, or are breastfeeding, tell your doctor before Ranluspec is prescribed. Many injectable medicines are used during pregnancy only when the expected benefit to the mother clearly outweighs the potential risk to the baby. Some medicines can pass into breast milk and reach the nursing infant, which may require temporary interruption of breastfeeding or use of an alternative medicine.

• A pregnancy test may be performed before treatment starts, particularly if the prescribing information requires it
• Effective contraception may be recommended during treatment and for a defined period afterwards
• If you become pregnant unexpectedly during treatment, contact your doctor as soon as possible for advice
• Do not start, stop, or alter any medicine in pregnancy or breastfeeding without professional guidance

Driving and Operating Machinery

Some injectable medicines can cause drowsiness, dizziness, blurred vision, or transient weakness. Until you know how Ranluspec affects you, avoid driving, operating heavy machinery, or performing other tasks that require full attention. Your doctor or pharmacist can advise whether any specific restrictions apply to this medicine based on its product information.

Children and Adolescents

The safety and effectiveness of Ranluspec in children and adolescents depend on the conditions for which it has been authorised. Not every injectable medicine is approved for paediatric use, and even when it is, doses and monitoring usually differ from those recommended for adults. Only a doctor with expertise in caring for children should prescribe injectable medicines for young patients.

How Does Ranluspec Interact with Other Drugs?

Ranluspec may interact with other prescription medicines, over-the-counter products, and herbal supplements. Always tell your healthcare team about every medicine you take, including anticoagulants, immunosuppressants, other injectables, and live vaccines, so that interactions can be anticipated and managed.

Drug interactions occur when one medicine changes how another medicine works. They can reduce effectiveness, increase side effects, or occasionally cause serious harm. Because injectable medicines reach the bloodstream quickly and often achieve higher peak concentrations than oral products, interactions can sometimes appear more rapidly. A full, up-to-date medication list helps your healthcare team evaluate risk before prescribing Ranluspec and during ongoing treatment.

Major Interactions

Minor Interactions and Lifestyle Factors

Not all interactions are serious, but minor ones can still affect comfort or convenience. For example, certain pain relievers, antihistamines, or sleep aids may add to drowsiness associated with injectable therapies. Alcohol can increase the risk of some side effects, such as dehydration or dizziness. Smoking and caffeine intake may affect blood pressure and heart rate, which can matter when new injectable treatments are started. Share your typical habits with your healthcare team so that they can offer practical advice tailored to you.

Over-the-Counter Medicines and Supplements

It is a common misconception that non-prescription products cannot cause interactions. In reality, many over-the-counter medicines, vitamins, minerals, and herbal remedies can influence prescription therapy:

• Non-steroidal anti-inflammatory drugs (NSAIDs) may affect kidney function and bleeding risk
• St John's wort can alter the activity of enzymes that metabolise many medicines
• Grapefruit juice affects some drug-metabolising enzymes in the gut and liver
• High-dose vitamin or mineral supplements may interact with certain medicines

Bring all medicines, including supplements, in their original containers to your prescribing appointment whenever possible. Your pharmacist can perform a structured medicines review to identify and manage potential interactions.

What Is the Correct Dosage of Ranluspec?

The dose of Ranluspec is determined by your prescriber and is individualised to your condition, age, weight, organ function, and other medicines you take. Because the product is a 10 mg/ml injectable solution, the volume injected directly reflects the dose in milligrams. Never adjust the dose or schedule yourself.

Injectable prescription medicines are almost always dosed with more precision than their oral counterparts because small volumes translate into relatively large amounts of active substance. With Ranluspec at a concentration of 10 mg/ml, each millilitre injected delivers 10 milligrams of active ingredient; each 0.1 ml therefore delivers 1 milligram. This proportionality makes accurate measurement essential — a deviation of just 0.2 ml represents a 2 mg difference in dose.

Your prescriber will specify the dose, the injection site, the injection technique (subcutaneous, intramuscular, or intravenous, depending on the product information), the frequency, and the total duration of treatment. Never assume a dose calculated for another person applies to you. Age, body weight, kidney and liver function, other illnesses, and concomitant medicines can all shift the right dose up or down.

Adults

Children

Elderly

Patients with Kidney or Liver Impairment

Missed Dose

Overdose

Injection Technique and Site Care

When a patient or carer is trained to administer Ranluspec at home, correct technique is essential. Key safety principles apply to any injectable medicine:

• Wash hands thoroughly and work on a clean surface
• Check the product label and expiry date before every injection
• Inspect the solution — it should be clear and free of particles; do not use if it looks abnormal
• Rotate injection sites to reduce skin irritation and lumps
• Use a new, sterile needle and syringe for every injection
• Dispose of needles and syringes in an approved sharps container and return full containers to a pharmacy for safe destruction

What Are the Side Effects of Ranluspec?

Like all medicines, Ranluspec can cause side effects, although not everyone experiences them. The most common effects are usually related to the injection site or to general reactions such as headache or tiredness. Serious allergic reactions are rare but possible and require immediate medical attention.

Side effects are classified by how often they occur in clinical studies and post-marketing reports. Understanding these frequencies helps you know what to expect and when to seek medical advice. The categories below follow the classification used in European product information and are typical of the frequency bands your patient information leaflet will use.

Frequency Categories

Managing Common Side Effects

Most common side effects of injectable medicines are mild, appear shortly after the injection, and resolve within hours to a few days. Practical steps that often help include resting after the injection, drinking fluids, applying a cool compress to the injection site, and taking paracetamol (if allowed by your doctor) for headache or mild fever. If any side effect persists, worsens, or interferes with daily life, contact your healthcare team.

Reporting Side Effects

You can actively help make medicines safer. If you experience any side effect — whether listed in the patient information leaflet or not — tell your doctor, pharmacist, or nurse. In many countries you can also report directly to the national pharmacovigilance authority:

• United Kingdom: MHRA Yellow Card scheme
• United States: FDA MedWatch
• European Union: national competent authorities listed on the EMA website
• International: WHO Programme for International Drug Monitoring

Reports from patients and healthcare professionals are a major source of new safety information and help regulators identify rare or previously unknown effects of medicines.

How Should You Store Ranluspec?

Store Ranluspec exactly as described in the patient information leaflet supplied with your medicine. Injectable solutions typically require refrigeration at 2 to 8 degrees Celsius, protection from light and freezing, and must be kept out of the reach of children. Do not use after the expiry date and return unused medicine to a pharmacy.

Correct storage preserves the sterility, potency, and safety of injectable medicines. Exposure to incorrect temperatures, light, or contamination can reduce effectiveness or make the product unsafe. For Ranluspec, the exact storage conditions are printed on the outer carton and inside the patient information leaflet, and these instructions always take precedence over general advice.

Typical Storage Conditions for Injectable Solutions

• Temperature: Most injectable prescription solutions are stored in a refrigerator between 2°C and 8°C. Check the leaflet to confirm whether this applies to Ranluspec
• Protection from light: Keep the medicine in its original carton or container to protect it from light until immediately before use
• Do not freeze: Freezing can damage injectable proteins and solutions. If the product has been accidentally frozen, do not use it — return it to your pharmacy
• Keep out of sight and reach of children: Store the medicine in a locked or elevated location to prevent accidental access

In-Use Stability

Once an ampoule, vial, or pre-filled syringe of Ranluspec has been opened, the remaining solution may have a limited shelf life, often only a few hours. Discard any unused portion after administration unless the product information specifically allows storage of partially used containers. Never combine the contents of multiple containers to achieve a dose unless specifically directed by the product information.

Travel Storage

If you need to travel with Ranluspec, plan ahead. For refrigerated products, use a validated cool bag with ice packs — but ensure the medicine does not come into direct contact with ice and is not frozen. On aeroplane flights, carry the medicine in your hand luggage with a letter from your prescriber explaining its purpose. Never leave injectable medicines in a hot car or direct sunlight, even briefly.

Disposal of Used Needles and Unused Medicine

Injectable medicines and the sharps used to give them require special disposal to protect other people and the environment. Always:

• Place used needles and syringes in an approved sharps container immediately after use
• Never place sharps in household waste or recycling
• Return full sharps containers and any unused or expired Ranluspec to a pharmacy
• Do not pour unused medicine down the sink or toilet

What Does Ranluspec Contain?

Ranluspec contains ranluspec as its active substance at a concentration of 10 mg per millilitre of sterile solution. The formulation also contains inactive excipients such as buffer salts, tonicity adjusters, and water for injections, which are listed in full in the patient information leaflet.

Every approved injectable medicine contains two categories of ingredients: the active substance that produces the therapeutic effect, and the excipients (sometimes called inactive ingredients) that make the formulation stable, sterile, isotonic with blood, and tolerable at the injection site. Understanding what is in your medicine is particularly important if you have allergies, follow a specific diet, or have had reactions to injection preparations in the past.

Active Substance

• ranluspec — 10 milligrams per millilitre of solution

Excipients (Inactive Ingredients)

The formulation typically includes:

• Buffer system — to maintain a pH close to physiological levels and reduce pain or tissue irritation at the injection site
• Tonicity adjuster (such as sodium chloride or glucose) — to match the osmotic pressure of blood
• Stabilisers — to protect the active substance from degradation during storage
• Preservatives — when the container is designed for multiple uses; single-use ampoules typically do not contain preservatives
• Water for injections — highly purified, sterile water used as the solvent

The exact list of excipients for Ranluspec is stated in the patient information leaflet inside the carton. If you know you are allergic to a specific excipient, check the leaflet before the first injection and alert your prescriber.

Appearance and Packaging

Ranluspec is a sterile solution for injection. The solution is typically clear and supplied in single-use ampoules, vials, or pre-filled syringes. Pack sizes authorised in your country are printed on the outer carton. Not all pack sizes may be marketed in every region.

Marketing Authorisation Holder and Manufacturer

Details of the marketing authorisation holder, local representative, and manufacturer of Ranluspec are printed in the patient information leaflet. If you have a question about the quality of the product you have received, contact your pharmacist or the manufacturer's medical information service using the contact details provided in the leaflet.